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ABSTRACT. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter implicated in the control
of generalized seizures induced by various convulsants. A specific anatomical site of action, the substantia
nigra (SN), has been shown to be involved in the GABA mediation of seizures. It was the objective of this
study to investigate the GABA system in the SN and its response to seizures induced by the neuroexcitant
kainic acid (KA). Since there have been conflicting reports of the effects of convulsants on GABA-related
measures in some brain regions, with some reporting increases and others showing decreases, one purpose
of this investigation was to examine the directionality of changes in GABA content of the SN, along with
the magnitude of the effects of KA and the time course over which these effects were manifested. Rats were
injected intraperitoneally with either 12.5 mg/kg KA or saline. GABA and protein contents of the SN were
measured at 2, 16, 24 and 48 hrs subsequent to injection. The levels of GABA in the SN were found to in-
crease in KA-injected animals over control levels for all time intervals except the 16 hr condition. These re-
sults are generally in conflict with those obtained by many researchers using the activity of the GABA
synthetic enzyme glutamic acid decarboxylase (GAD) as a measure of GABA levels. It is suggested that
GABA levels may actually increase in response to convulsants and serve to negatively feed back to its syn-
thetic enzyme. Therefore, a decrease in GAD activity would not necessarily reflect a decrease in GABA lev-
els. Future research directions include enzyme studies of both GAD and GABA transaminase and their
regulation by products and substrates.
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INTRODUCTION
Gamma-aminobutyric acid (GABA) is a major in-
hibitory neurotransmitter in the central nervous system.
It is synthesized by the decarboxylation of glutamic
acid via the action of the enzyme glutamic acid decar-
boxylase (GAD). In the brain, GABA is synthesized by
shunting glutamate away from the Kreb's cycle at the
energetic expense of the cell, supporting the importance
of maintaining appropriate levels of the neurotransmit-
ter. After release from the presynaptic terminal, GABA
is either taken up into the mitochondria of neurons and
glial cells, or is degraded to succinic semialdehyde by
the actions of GABA transaminase (GABA-T). Succinic
semialdehyde can be oxidized to succinic acid and can
reenter the Kreb's cycle, maintaining a self-regenerat-
ing synthesis loop (Stryer 1988).
GABA is found in relatively high concentrations in
the pituitary gland and in many brain regions, as well
as in hypophyseal portal blood. Mugnaini and Oertel
(1985) demonstrated the distribution of GABA cell
bodies and presynaptic terminals in the rat brain by im-
munohistochemical localization of the GABA synthetic
enzyme GAD. Using these techniques, GABAergic cell
bodies and nerve terminals were found in a wide variety
of brain structures and regions, with high levels of
GAD immunoreactivity measured in the substantia ni-
gra (SN), among other areas. The high GAD content in
this structure synthetically provides the GABA con-
tained in terminals within the striatum. The SN has
been implicated as the primary site of GABA-mediated
control of induced seizures, and in the pathology of
Parkinson's disease and Huntington's chorea (Kandel
and Schwartz 1985).
'Manuscript received 11 April 1989 and in revised form 1 June
1989 (#89-13).
Present Address: Department of Biochemistry, Medical College
of Ohio, C. S. 10008, Toledo, Ohio 43699.
To whom requests for reprints should be sent.
The role of GABA in the control of generalized in-
duced seizures in laboratory animals has been well doc-
umented. A number of studies have shown that GABA
or its analogues such as muscimol, when administered
centrally, have controlled seizures induced by GABA-
antagonistic convulsants such as bicuculline (Iadorola
and Gale 1982) and kainic acid (KA) (Albala et al.
1984). Kainic acid (a glutamate analogue) has been
used by many researchers to induce seizures that are
thought to mimic the pathological state of epilepsy and
other convulsive disorders (e.g., Armstrong et al. 1986,
Lothman and Collins 1981).
In the present study, the focus was directed to deter-
mination of the relationship between seizures induced
by systemic administration of the glutamate analogue
kainic acid and the GABA system in the substantia ni-
gra. The relationship between kainic acid and GABA-
related measures has been reviewed by Coyle et al. (1978).
It was suggested that KA administration consistently
reduced GAD levels, and by implication GABA levels,
in the brain regions studied. However, this view of GABA
reduction in response to convulsants has recently been
challenged. Ruth and Seimen (1988) found that GABA
concentration in the hippocampus was 19% higher in
rats treated with systemic KA than in control rats.
The objective of the present study was to more directly
assess the changes in GABA content of the substantia
nigra in response to systemic kainic acid administration
and subsequent seizure activity. By making a direct es-
timate of GABA content of the SN, as opposed to the
activity of its synthetic enzyme, the magnitude and di-
rectionality of any change in GABA content could be
examined. It was also of interest to examine the course
of these changes over time.
MATERIALS AND METHODS
ANIMALS. Male albino rats were obtained from Harlan Sprague-
Dawley (Indianapolis, IN) at a body weight of 200 g and were
housed in the Life Sciences Animal Research Facility at Bowling
Green State University, where they were maintained and provided
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with food and water ad libitum and subjected to a 12 hr alternating
light/dark schedule until the time of the experiment.
Sixteen experimental (kainic acid injected) and sixteen control (sa-
line injected) rats were divided into groups of four for testing at 2,
16, 24, or 48 hrs after injection. This gave a total of four experi-
mental and four control rats per time point studied. The number of
animals at each time point was minimized because of the obvious
noxious effects of KA administration.
Rats were injected intraperitoneally with 12.5 mg/kg body
weight kainic acid (Sigma Chemical Company, St. Louis, MO) or
with an equivalent volume of injection vehicle (0.9% saline) and
tested for GABA content of the substantia nigra at the appropriate
time after injection. The rats were killed by decapitation, brains
were quickly removed from the skull, and a 3-0 mm slice of brain
was excised using the posterior hypothalamus as the rostral edge and
the anterior pons as the caudal edge of the slice. Substantiae nigrae
were visualized in the slice by pigmentation, dissected free, weighed
and homogenized for use in protein and GABA assays.
EXTRACTION. The substantiae nigrae were homogenized in
150 fli of ice-cold 0.5M perchloric acid containing 1 mM EDTA.
The homogenate was then neutralized with an equal volume of cold
KHCO3. After 50 /xl of homogenate was removed for determination
of protein concentration, the remainder was centrifuged at 16,400 X g
for 30 min. The supernatant was used for GABA determination.
ASSAYS. Protein content was determined using the method of
Lowry et al. (1951).
GABA content in the tissue extracts was determined using the
spectrophotofluorimetric method of Okada et al. (1971). Briefly,
100 /xl of supernatant from each sample was added to 150 /xl of the
following solution: 0.1M tris-HCl buffer (pH 8.6), 3-2 mM a-ke-
toglutarate, 0.5 mM NADP, 8 mM 2-mercaptoethanol. Sixty-nine
/il of Gabase (2.55 units/ml) was added to each tube. After incuba-
tion for 50 min at 22°C, 800 /xl of 0. 1 M tris-HCl buffer (pH 7.6)
was added. GABA, Gabase, NADP and a-ketoglutarate were ob-
tained from Sigma Chemical Company (St. Louis, MO).
Fluorescence of samples and standards was read in a volume of
1 ml using a SPEX 212 FLOUROLOG spectrofluorimeter with ex-
citation wavelength set at 350 nm and emission wavelength set at
460 nm. Intensity of fluorescence, expressed as counts/sec, was
measured at one sec intervals for 60 sec, then averaged. After sub-
traction of the blank from each sample and standard, a standard
curve was generated and GABA content of the sample was derived. The
blank consisted of 50 /xl of distilled water, in place of homogenate,
added to the assay reagents. Standards contained from 2-100 nmoles
GABA and were run in parallel with samples.
Concentrations were calculated and statistical analyses were per-
formed on the data set expressed as nmoles GABA per substantia ni-
gra, since an overall analysis of variance (ANOVA) showed no
significant difference between experimental and control groups with
respect to protein content. With respect to GABA content, ANOVA
was also performed and showed significant differences between the
saline-injected and the KA-injected groups. Thus, paired t-tests were
performed to find which groups contributed to these significant dif-
ferences. Since the GABA content of the experimental and control
groups did not follow parallel functions, an analysis of trend (method
of orthogonal polynomials) (Keppel 1982) was conducted to deter-
mine which component of the experimental function was significant.
RESULTS
Kainic acid did not significantly modify tissue pro-
tein content, which ranged from 390 /Ltg to 470 fJLg
protein per SN (Table 1). Analysis of variance revealed
that the KA-injected rats exhibited significantly higher
levels of GABA in the substantia nigra than the control
rats (p < 0.025), and that there were significant differ-
ences in GABA content among rats in the different
time conditions (p < 0.01) (Fig. 1). When collapsed
across treatments, the 2 hr and 16 hr rats had higher
GABA values than the 24 hr and 48 hr rats. Analysis of
trend revealed that the linear component was the sig-
nificant trend in the function (p < 0.05), indicating
that the change in GABA content in the SN in response
to KA generally followed a linear decrease over time,
while still remaining above control values.
TABLE 1
Mean protein content in fxg protein!substantia nigra in kainic acid and




Saline: 420 ± 7 0 410 ± 40 430 ± 30 470 ± 50
Kainic Acid: 440 ± 50 390 ± 3 0 410 ± 50 410 ± 30
DISCUSSION
The average protein content found in the substantiae
nigrae in this study was consistent with those in other
investigations. For example, Gale and Iadorola (1980)
found that a single substantia nigra contained approxi-
mately 400 fig protein as compared to 390 /ug to 470 \xg
in the present study. The control levels of GABA in the
SN found here are generally lower than those reported
in other studies, although some values approached those
previously reported. The lower values may be explained
by the rapid degradation of GABA immediately after
death. At any rate, factors which contributed to the
degradation would have been consistent throughout the
course of this study.
The significant increase in the GABA content of the
SN seen 2 hr following KA injection in the present
study is not consistent with the findings of some re-
searchers. This short time interval for the initial manifes-
tation of KA effects has not been previously described.
Several studies included measures taken many hours or
days after treatment. The direction of the effect is also
different from that described in previous studies. Coyle
(1983), when using GAD activity as a measure of GABA
levels, found decreases in response to injected convul-
sants. The contradictory results found here may be ex-
plained by intracellular mobilization of the inhibitory
neurotransmitter in response to the neuroexcitant. There
have been documented increases in the metabolic activ-
ity of the SN in response to KA (Lothman and Collins
1981), suggesting a compensatory mechanism. That is,
it may be that GABA is being synthesized and released
in large amounts to compensate for the excitatory effects
Time (Hrs after injection)
FIGURE 1. Mean GAB A content in substantiae nigrae of kainic acid
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of KA. Following this line of reasoning, the establish-
ment of a plateau of GABA content in the treated rats at
a concentration well above control values may indicate a
longer term mechanism by which the system protects
itself from subsequent exposures to the excitotoxin.
A previously described consistently irreversible decrease
of GABA in response to convulsants (Coyle 1983) is not
confirmed by the present study. The decreases in GAD
activity found by other researchers may not accurately
indicate GABA availability. If oversynthesis of GABA
serves to negatively regulate its own synthesis, it is con-
ceivable that an increase in GABA might decrease the
activity of its synthetic enzyme.
The results of this study are in agreement with those
of Ruth and Seimen (1988), who found GABA concen-
tration in the hippocampi of rats treated with systemic
KA to be higher than that in control rats. As in the
present study, these effects were observed at relatively
short time intervals after injection of KA, indicating
that they may be of shorter latency and duration than
the previously indicated results. It is clear that this
problem deserves closer examination to resolve apparent
discrepancies. Histological and localization studies may
reveal the source of the neurotransmitter and related
substances which mediate the action of KA in the brain,
along with an idea of any degeneration which may occur
in response to the excitotoxin. Enzyme studies may shed
more light on the effects of systemic KA on the GABA
system in the substantia nigra. Changes in GAD and
GABA-T levels and activity would indicate a mecha-
nism whereby GABA levels may be altered by the treat-
ment. The excitotoxin could act at the level of the
synthetic or degradative enzyme, affecting the final mea-
sure of GABA content in the substantia nigra.
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